COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL

COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL

The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PATEL, Manit, JADHAV, Vishal, Anant, RADDA, Rusinova, RUBEN, Peter, Charles, FOUDA, Mohamed, Amin, GHOVANLOO, Mohammad-Reza, CHOUDHURY, Koushik, PHATERPEKAR, Tejas, PAGE, Dana, A
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PATEL, Manit
JADHAV, Vishal, Anant
RADDA, Rusinova
RUBEN, Peter, Charles
FOUDA, Mohamed, Amin
GHOVANLOO, Mohammad-Reza
CHOUDHURY, Koushik
PHATERPEKAR, Tejas
PAGE, Dana, A
description The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceutical composition employing the new therapeutic agent cannabidiol for abolishing or minimizing side effects of other therapeutic agents / drugs which induce, or which are likely to induce Long QT. The invention further provides pharmaceutical composition of cannabidiol for treating or avoiding inflammation induced by any other therapeutic agent or inflammation induced in any diseases or ailment such as Covid-19 and also inflammation induced by any vaccine such as Covid-19 vaccine.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA202210355B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA202210355B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA202210355B3</originalsourceid><addsrcrecordid>eNrjZDBw9vcN8A_2DPH09wtWcPRzUQjxcA1yDHANDfF0VggNdg1W8HdTcHb083N08nTx9PfhYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxUY5GBkZGhgbGpqZOxsSoAQA60SZW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL</title><source>esp@cenet</source><creator>PATEL, Manit ; JADHAV, Vishal, Anant ; RADDA, Rusinova ; RUBEN, Peter, Charles ; FOUDA, Mohamed, Amin ; GHOVANLOO, Mohammad-Reza ; CHOUDHURY, Koushik ; PHATERPEKAR, Tejas ; PAGE, Dana, A</creator><creatorcontrib>PATEL, Manit ; JADHAV, Vishal, Anant ; RADDA, Rusinova ; RUBEN, Peter, Charles ; FOUDA, Mohamed, Amin ; GHOVANLOO, Mohammad-Reza ; CHOUDHURY, Koushik ; PHATERPEKAR, Tejas ; PAGE, Dana, A</creatorcontrib><description>The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceutical composition employing the new therapeutic agent cannabidiol for abolishing or minimizing side effects of other therapeutic agents / drugs which induce, or which are likely to induce Long QT. The invention further provides pharmaceutical composition of cannabidiol for treating or avoiding inflammation induced by any other therapeutic agent or inflammation induced in any diseases or ailment such as Covid-19 and also inflammation induced by any vaccine such as Covid-19 vaccine.</description><language>eng</language><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240228&amp;DB=EPODOC&amp;CC=ZA&amp;NR=202210355B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240228&amp;DB=EPODOC&amp;CC=ZA&amp;NR=202210355B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PATEL, Manit</creatorcontrib><creatorcontrib>JADHAV, Vishal, Anant</creatorcontrib><creatorcontrib>RADDA, Rusinova</creatorcontrib><creatorcontrib>RUBEN, Peter, Charles</creatorcontrib><creatorcontrib>FOUDA, Mohamed, Amin</creatorcontrib><creatorcontrib>GHOVANLOO, Mohammad-Reza</creatorcontrib><creatorcontrib>CHOUDHURY, Koushik</creatorcontrib><creatorcontrib>PHATERPEKAR, Tejas</creatorcontrib><creatorcontrib>PAGE, Dana, A</creatorcontrib><title>COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL</title><description>The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceutical composition employing the new therapeutic agent cannabidiol for abolishing or minimizing side effects of other therapeutic agents / drugs which induce, or which are likely to induce Long QT. The invention further provides pharmaceutical composition of cannabidiol for treating or avoiding inflammation induced by any other therapeutic agent or inflammation induced in any diseases or ailment such as Covid-19 and also inflammation induced by any vaccine such as Covid-19 vaccine.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw9vcN8A_2DPH09wtWcPRzUQjxcA1yDHANDfF0VggNdg1W8HdTcHb083N08nTx9PfhYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxUY5GBkZGhgbGpqZOxsSoAQA60SZW</recordid><startdate>20240228</startdate><enddate>20240228</enddate><creator>PATEL, Manit</creator><creator>JADHAV, Vishal, Anant</creator><creator>RADDA, Rusinova</creator><creator>RUBEN, Peter, Charles</creator><creator>FOUDA, Mohamed, Amin</creator><creator>GHOVANLOO, Mohammad-Reza</creator><creator>CHOUDHURY, Koushik</creator><creator>PHATERPEKAR, Tejas</creator><creator>PAGE, Dana, A</creator><scope>EVB</scope></search><sort><creationdate>20240228</creationdate><title>COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL</title><author>PATEL, Manit ; JADHAV, Vishal, Anant ; RADDA, Rusinova ; RUBEN, Peter, Charles ; FOUDA, Mohamed, Amin ; GHOVANLOO, Mohammad-Reza ; CHOUDHURY, Koushik ; PHATERPEKAR, Tejas ; PAGE, Dana, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA202210355B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>PATEL, Manit</creatorcontrib><creatorcontrib>JADHAV, Vishal, Anant</creatorcontrib><creatorcontrib>RADDA, Rusinova</creatorcontrib><creatorcontrib>RUBEN, Peter, Charles</creatorcontrib><creatorcontrib>FOUDA, Mohamed, Amin</creatorcontrib><creatorcontrib>GHOVANLOO, Mohammad-Reza</creatorcontrib><creatorcontrib>CHOUDHURY, Koushik</creatorcontrib><creatorcontrib>PHATERPEKAR, Tejas</creatorcontrib><creatorcontrib>PAGE, Dana, A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PATEL, Manit</au><au>JADHAV, Vishal, Anant</au><au>RADDA, Rusinova</au><au>RUBEN, Peter, Charles</au><au>FOUDA, Mohamed, Amin</au><au>GHOVANLOO, Mohammad-Reza</au><au>CHOUDHURY, Koushik</au><au>PHATERPEKAR, Tejas</au><au>PAGE, Dana, A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL</title><date>2024-02-28</date><risdate>2024</risdate><abstract>The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceutical composition employing the new therapeutic agent cannabidiol for abolishing or minimizing side effects of other therapeutic agents / drugs which induce, or which are likely to induce Long QT. The invention further provides pharmaceutical composition of cannabidiol for treating or avoiding inflammation induced by any other therapeutic agent or inflammation induced in any diseases or ailment such as Covid-19 and also inflammation induced by any vaccine such as Covid-19 vaccine.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA202210355B
source esp@cenet
title COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T04%3A35%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PATEL,%20Manit&rft.date=2024-02-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA202210355B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true